Efficacy and Safety Results of Long-Term Growth Hormone Treatment of Idiopathic Short Stature

Abstract

ISS patients in the GH registry demonstrate a significant increase in HtSDS with the safety profile similar to GH-deficient patients. RESULTS were similar to the clinical trial.